Melbourne colorectal collaboration: a multicentre review of the impact of COVID-19 on colorectal cancer in Melbourne, Australia
Michelle Zhiyun Chen,Yeng Kwang Tay,Wiliam Mk Teoh,Joseph Ch Kong,Peter Carne,Basil D'Souza,Raaj Chandra,Andrew Bui,Melbourne Colorectal Collaboration,Cody Gu,Azhar Auckloo,Rebecca Pearce,Hannah Mckenna,Stephanie Ying Li,Ryan William Lowe,Jack Li,David Duong,Sally Jiasi Chen,Shoa Zafir,Matthew Ng,Nicole Tan,Jack Maida,Kit Chong,Maggie Gao,Daniel You,Kathy Zhang,Thomas Tiang,Vivek Jayapadman,Timothy Gregory Chatsionok,David Zula,Amos Nepacina Liew,Kevin Kah Wai Yoong,Ashwin Madhavan,Bryan Lim,Caroline Younan,Emily Whalen,Hailey Miller,Jason Zhang,Jessica Wang,Kyle Williams,Meghna Burmi,Morika Ra,Lap Wah Tsui,Qiao Wen Tee,Sandra Li,Sheree Chen,Stephanie Cameron,Vicky Wei-Ching Chen,Virginia Su,Anshini Jain,Ally Hui,Aishwarya Manivannan,Chen Lew,Diya Patel,Erica Wang,Ivan Chan,Jasman Bedi,Jocelyn Widjaja,Matthew Kaufman,Molly Maxwell,Michelle Yao,Melanie Zhang,Natasha Newman,Poojani Pathirana,Rami Dennaoui,Sarah Goh,Sarita Surendran,Shanaya Mendis,Shivangi Gupta,Zoe Poulos,Baxter Smith,Aya Basam,Jordi Elliott,Zahin Mosharaf,Shani Nguyen,Ching Clarise Lam,Zhuoning Song,Faizah Alam,Qiaoran Tu,Stella Le,Arsheeya Rattan,Emma Aldous,Bill Wang,Jiting Li,Pranjal Chaurasia,Lachlan Snooks
DOI: https://doi.org/10.1111/ans.17603
Abstract:Background: As coronavirus (COVID-19) cases continue to rise, healthcare workers have been working overtime to ensure that all patients receive care in a timely manner. Our study aims to identify the impact and outcomes of COVID-19 on colorectal cancers presentations across the five major colorectal units in Melbourne, Australia. Methods: This is a retrospective study from a prospectively collected database from the binational colorectal cancer audit (BCCA) registry, as well as inpatient records. All patients with colorectal cancer between Pre-COVID-19 period (1 July 2018-2030 June 2019) and COVID-19 period (1 July 2020-2030 June 2021) were compared. Benign pathology and other cancer types were excluded. Results: A total of 1609 patients were included in the study (700 Pre-COVID-19 period, 906 COVID-19 period). During COVID-19 period, there was a higher proportion of emergency surgery (28.1% vs. 19.8%; P < 0.001), a higher nodal (P = 0.024) and metastatic stage (P = 0.018) at presentation, but no increase in the rate of return to operating theatres (P = 0.240), inpatient death (P = 0.019) or 30-day readmission (P = 0.000). There was also no difference in the post-operative surgical complications (P = 0.118). Utility of neoadjuvant therapy did not increase during the pandemic (P = 0.613). Conclusion: The heightened measures in the healthcare system ensured CRC patients still received their surgery in a timely fashion. With the current rise in the new strain of COVID-19 (Omicron), we have to continue to come up with new strategies to provide timely access to CRC care.